Regulus Therapeutics reported $4.48M in Debt for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Astrazeneca AZN:US USD 29.3B 229M
AstraZeneca AZN:LN USD 29.3B 229M
Biogen BIIB:US USD 6.28B 998M
GlaxoSmithKline GSK:LN GBP 20.99B 1.13B
Intercept Pharmaceuticals ICPT:US USD 332.31M 381.55M
Intrexon XON:US USD 82.07M 116.6M
IONIS PHARMACEUT IONS:US USD 1.25B 1.34M
Ligand Pharmaceuticals LGND:US USD 76.65M 38.38M
Omeros OMER:US USD 439.82M 125.46M
Regulus Therapeutics RGLS:US USD 4.48M 32K
Takeda 4502:JP JPY 4.29T 449.74B
YTE INCY:US USD 33.59M 605K